(Q46399532)

21 December 2017

title

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis (English)

1 reference

21 December 2017

1 reference

Ryszard Grenda

2

0 references

Isidro Salusky

10

object named as

Isidro B Salusky

1 reference

21 December 2017

author name string

Larry A Greenbaum

1

1 reference

21 December 2017

Ping Qiu

3

1 reference

21 December 2017

Irene Restaino

4

1 reference

21 December 2017

Amy Wojtak

5

1 reference

21 December 2017

Ana Paredes

6

1 reference

21 December 2017

Nadine Benador

7

1 reference

21 December 2017

Joel Z Melnick

8

1 reference

21 December 2017

Laura A Williams

9

1 reference

21 December 2017

publication date

23 March 2005

1 reference

21 December 2017

published in

Pediatric Nephrology

1 reference

21 December 2017

volume

20

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

622-630

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1007/s00467-004-1792-6

exact match

0 references

cites work

Calcimimetic agents and secondary hyperparathyroidism: treatment and prevention

1 reference

12 December 2020

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

12 December 2020

Improved cadaveric renal transplant outcome in children

1 reference

12 December 2020

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

12 December 2020

Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.

1 reference

12 December 2020

Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

1 reference

12 December 2020

Bone and mineral metabolism in childhood end-stage renal disease.

1 reference

12 December 2020

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

12 December 2020

Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells

1 reference

12 December 2020

Demographic and medical predictors of medication compliance among ethnically different pediatric renal transplant patients

1 reference

12 December 2020

No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism

1 reference

12 December 2020

Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells

1 reference

12 December 2020

Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus

1 reference

12 December 2020

Control of phosphate excretion in uremic man

1 reference

12 December 2020

The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease

1 reference

12 December 2020

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

1 reference

12 December 2020

Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol

1 reference

12 December 2020

Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol

1 reference

12 December 2020

Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism

1 reference

12 December 2020

Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital

1 reference

12 December 2020

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

1 reference

12 December 2020

Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro

1 reference

12 December 2020

Pathogenesis of secondary hyperparathyroidism

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

12 December 2020

The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.

1 reference

12 December 2020

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Long-term effect of intravenous calcitriol on the treatment of severe hyperparathyroidism, parathyroid gland mass and bone mineral density in haemodialysis patients

1 reference

12 December 2020

Coordinate regulation of PTH/PTHrP receptors by PTH and calcitriol in UMR 106-01 osteoblast-like cells

1 reference

12 December 2020

Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

12 December 2020

10.1007/S00467-004-1792-6

Identifiers

DOI

1 reference

21 December 2017

release_kmluxvnqxrelhcz5rq24ivel7m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kmluxvnqxrelhcz5rq24ivel7m

24 November 2022

mapped directly with Wikidata item

1 reference

21 December 2017